Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-15T03:25:44.001Z Has data issue: false hasContentIssue false
  • English
  • Français

Validation of the German Version of the Brief Assessment of Cognition in Schizophrenia (BACS) – Preliminary Results

Published online by Cambridge University Press:  27 April 2010

G. Sachs ,
B. Winklbaur ,
R. Jagsch  and
R.S.E. Keefe
G. Sachs*
Affiliation:
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria
B. Winklbaur
Affiliation:
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria
R. Jagsch
Affiliation:
Institute of Clinical, Biological and Differential Psychology, University of Vienna, Liebiggasse 5, 1010 Vienna, Austria
R.S.E. Keefe
Affiliation:
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, P.O. Box 3270, Durham, NC 27710, USA
*
⁎Corresponding author. Tel.: +431404003547; fax: +431404003560. E-mail address:[email protected] (G. Sachs).
Get access

Abstract

The German version of the BACS showed high test-retest reliability. Sensitivity and specificity scores demonstrated good ability to differentiate between patients and controls. The study suggests that the German Version of the BACS is a useful scale to evaluate cognitive functioning.

Keywords

Brief Assessment of Cognition in Schizophrenia (BACS)German versionCognitive functionSchizophreniaNeurocognitive assessments
Type
Short communication
Information
European Psychiatry , Volume 26 , Issue 2 , March 2011 , pp. 74 - 77
Copyright
Copyright © Elsevier Masson SAS 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anselmetti, S.Poletti, S.Ermoli, E.Bechi, M.Cappa, S.Venneri, A., et al.The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population. Neurol Sci 2008; 29: 85–95CrossRefGoogle ScholarPubMed
Beck, A.T.Ward, C.H.Mendelson, M.Mock, J.E.Erbaugh, J.K.An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–571CrossRefGoogle ScholarPubMed
Bralet, M.C.Falissard, B.Neveu, X.Lucas-Ross, M.Eskenazi, A.M.Keefe, R.S.E.Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients. Eur Psychiatry 2007; 22: 365–370CrossRefGoogle ScholarPubMed
First, M.G.Spitzer, R.L.Gibbon, M.Williams, J.B.Structured Clinical Interview for DSM-IV Patient Edition (SCID-P). New York: Biometrics Research Department, New York State Psychiatric Institute: 1995Google Scholar
First, M.G.Spitzer, R.L.Gibbon, M.Williams, J.B.Structured Clinical Interview for DSM-IV Axis I Disorders Non-Patient Edition (SCID-NP). New York: Biometrics Research Department, New York State Psychiatric Institute: 1995Google Scholar
Green, M.F.Mediators between neurocognitive deficits and community outcome in schizophrenia. J Adv Schizophr Brain Res 2002; 4: 3–7Google Scholar
Green, M.F.Nuechterlein, K.H.Gold, J.M.Barch, D.Cohen, J.Essock, S., et al.Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 5652004; 301-307CrossRefGoogle ScholarPubMed
Hill, S.K.Sweeney, J.A.Hamer, R.M.Keefe, R.S.Perkins, D.O.Gu, H., et al.Efficiency of the CATIE and the BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia. J Int Neuropsychol Soc 2008; 14: 209–221CrossRefGoogle Scholar
Harvey, P.D.Keefe, R.S.E.Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment. CNS Spectr 1997; 2: 1–11Google Scholar
Kaneda, Y.Sumiyoshi, T.Keefe, R.S.Ishimoto, Y.Numata, S.Ohmori, T.Brief Assessment of Cognition in Schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosc 2007; 61: 602–609CrossRefGoogle ScholarPubMed
Kay, S.R.Fiszbein, A.Opler, L.A.The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276CrossRefGoogle Scholar
Keefe, R.S.Goldberg, T.E.Harvey, P.D.Gold, J.M.Poe, M.P.Coughenour, L.The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 682-32004; 283-297CrossRefGoogle ScholarPubMed
Keefe, R.S.Sweeney, J.A.Gu, H.Hamer, R.M.Perkins, D.O.McEvoy, J.P.Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 16472007; 1061-1071CrossRefGoogle ScholarPubMed
Keefe, R.S.Harvey, P.D.Goldberg, T.E.Gold, J.M.Walker, T.M.Kennel, C., et al.Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res 1021–32008; 108-115CrossRefGoogle Scholar
Lehrl, S.Merz, J.Burkhard, G.Fischer, S.Mehrfach-Wortschatz Test. Göttingen: Hogrefe: 1991Google Scholar
Sharma, T.Antonova, L.Cognitive function in schizophrenia. Deficits, functional consequences and future treatment. Psychiatr Clin North Am 2612003; 25-40CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.